Nath Bio-Genes (NATHBIOGEN) | Stock Overview & Key Data

What is NATHBIOGEN's 52-week high and low?

In the last 52 weeks, Nath Bio-Genes reached a high of ₹238.69 (on July 10, 2025) and a low of ₹137.55 (on March 12, 2025).

What is the market cap and P/E ratio for NATHBIOGEN?

Curious about Nath Bio-Genes's size and valuation? Its market capitalization stands at 3.27B. When it comes to valuation, the P/E ratio (trailing twelve months) is 8.04, and the forward P/E (looking ahead) is N/A.

Does NATHBIOGEN pay dividends? If so, what's the yield?

Yes, Nath Bio-Genes is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.17%, and the company has paid an average of ₹2.00 per share annually over the past 3 years.

Who are Nath Bio-Genes's main competitors or similar companies to consider before investing?

When looking at Nath Bio-Genes, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Coromandel COROMANDEL	693.75B	Basic Materials	Agricultural Inputs	33.72%	128.12%
UPL UPLPP	622.77B	Basic Materials	Agricultural Inputs	104.96%	104.96%
Bharat Rasayan BHARATRAS	45.78B	Basic Materials	Agricultural Inputs	-15.72%	-8.92%
National Fertilizers NFL	45.02B	Basic Materials	Agricultural Inputs	-30.74%	88.25%
Mangalore Chemicals MANGCHEFER	40.69B	Basic Materials	Agricultural Inputs	156.77%	177.98%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Nath Bio-Genes (India) Limited? (e.g., ROE, Debt/Equity)

To get a sense of Nath Bio-Genes's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 5.99%, the Debt to Equity ratio from the most recent quarter is 19.01, and its Gross Profit Margin stands at 50.71%.

What is the recent revenue and earnings growth for NATHBIOGEN?

Looking at Nath Bio-Genes's growth, its revenue over the trailing twelve months (TTM) was INR4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 16.30%, and quarterly earnings saw a YoY growth of 11.80%.

How much of NATHBIOGEN stock is held by insiders and institutions?

Wondering who owns Nath Bio-Genes stock? Company insiders (like executives and directors) hold about 59.17% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 3.20%.

For more common questions about our data, please visit our About Data page.